Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 312 entries
Sorted by: Best Match Show Resources per page
Development and validation of a short version of Chronic Oral Mucosal Disease Questionnaire (COMDQ-15).

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology

Wiriyakijja P, Porter S, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain R.
PMID: 31605549
J Oral Pathol Med. 2020 Jan;49(1):55-62. doi: 10.1111/jop.12964. Epub 2019 Oct 28.

BACKGROUND: The adoption of the Chronic Oral Mucosal Disease Questionnaire (COMDQ) into clinical practice has been low, despite its rigorous development process. A potential limitation of the COMDQ is the high response burden to patients. Therefore, the aim of...

Cite
Wiriyakijja P, Porter S, Fedele S, et al. Development and validation of a short version of Chronic Oral Mucosal Disease Questionnaire (COMDQ-15). J Oral Pathol Med. 2019;49(1):55-62doi: 10.1111/jop.12964.
Wiriyakijja, P., Porter, S., Fedele, S., Hodgson, T., McMillan, R., Shephard, M., & Ni Riordain, R. (2020). Development and validation of a short version of Chronic Oral Mucosal Disease Questionnaire (COMDQ-15). Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 49(1), 55-62. https://doi.org/10.1111/jop.12964
Wiriyakijja, Paswach, et al. "Development and validation of a short version of Chronic Oral Mucosal Disease Questionnaire (COMDQ-15)." Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology vol. 49,1 (2020): 55-62. doi: https://doi.org/10.1111/jop.12964
Wiriyakijja P, Porter S, Fedele S, Hodgson T, McMillan R, Shephard M, Ni Riordain R. Development and validation of a short version of Chronic Oral Mucosal Disease Questionnaire (COMDQ-15). J Oral Pathol Med. 2020 Jan;49(1):55-62. doi: 10.1111/jop.12964. Epub 2019 Oct 28. PMID: 31605549.
Copy Download .nbib Format: NLM
Transforming an Autism Pediatric Research Network into a Learning Health System: Lessons Learned.

Pediatric quality & safety

Murray DS, S Anixt J, Coury DL, Kuhlthau KA, Seide J, Kelly A, Fedele A, Eskra D, Lannon C.
PMID: 31321366
Pediatr Qual Saf. 2019 Apr 02;4(2):e152. doi: 10.1097/pq9.0000000000000152. eCollection 2019.

INTRODUCTION: The Autism Speaks Autism Treatment Network that serves as the Autism Intervention and Research Network on Physical Health (ATN/AIR-P) has a mission to improve the health and well-being of children with Autism Spectrum Disorder and determine the best...

Cite
Murray DS, S Anixt J, Coury DL, et al. Transforming an Autism Pediatric Research Network into a Learning Health System: Lessons Learned. Pediatr Qual Saf. 2019;4(2):e152doi: 10.1097/pq9.0000000000000152.
Murray, D. S., S Anixt, J., Coury, D. L., Kuhlthau, K. A., Seide, J., Kelly, A., Fedele, A., Eskra, D., & Lannon, C. (2019). Transforming an Autism Pediatric Research Network into a Learning Health System: Lessons Learned. Pediatric quality & safety, 4(2), e152. https://doi.org/10.1097/pq9.0000000000000152
Murray, Donna S, et al. "Transforming an Autism Pediatric Research Network into a Learning Health System: Lessons Learned." Pediatric quality & safety vol. 4,2 (2019): e152. doi: https://doi.org/10.1097/pq9.0000000000000152
Murray DS, S Anixt J, Coury DL, Kuhlthau KA, Seide J, Kelly A, Fedele A, Eskra D, Lannon C. Transforming an Autism Pediatric Research Network into a Learning Health System: Lessons Learned. Pediatr Qual Saf. 2019 Apr 02;4(2):e152. doi: 10.1097/pq9.0000000000000152. eCollection 2019. PMID: 31321366; PMCID: PMC6494227.
Copy Download .nbib Format: NLM
Retraction: HMGA Proteins Up-regulate .

Cancer research

De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P, Chiappetta G, Forzati F, Lombardi G, Colao A, Trouillas J, Fedele M, Fusco A.
PMID: 30552124
Cancer Res. 2018 Dec 15;78(24):6906. doi: 10.1158/0008-5472.CAN-18-3455.

No abstract available.

Cite
De Martino I, Visone R, Wierinckx A, et al. Retraction: HMGA Proteins Up-regulate . Cancer Res. 2018;78(24):6906doi: 10.1158/0008-5472.CAN-18-3455.
De Martino, I., Visone, R., Wierinckx, A., Palmieri, D., Ferraro, A., Cappabianca, P., Chiappetta, G., Forzati, F., Lombardi, G., Colao, A., Trouillas, J., Fedele, M., & Fusco, A. (2018). Retraction: HMGA Proteins Up-regulate . Cancer research, 78(24), 6906. https://doi.org/10.1158/0008-5472.CAN-18-3455
De Martino, Ivana, et al. "Retraction: HMGA Proteins Up-regulate ." Cancer research vol. 78,24 (2018): 6906. doi: https://doi.org/10.1158/0008-5472.CAN-18-3455
De Martino I, Visone R, Wierinckx A, Palmieri D, Ferraro A, Cappabianca P, Chiappetta G, Forzati F, Lombardi G, Colao A, Trouillas J, Fedele M, Fusco A. Retraction: HMGA Proteins Up-regulate . Cancer Res. 2018 Dec 15;78(24):6906. doi: 10.1158/0008-5472.CAN-18-3455. PMID: 30552124.
Copy Download .nbib Format: NLM
Rivaroxaban in atrial fibrillation cardioversion: an update.

Therapeutics and clinical risk management

Lavalle C, Straito M, Caroli A, Piro A, Giunta G, Mariani MV, Fedele F.
PMID: 31118649
Ther Clin Risk Manag. 2019 May 02;15:613-626. doi: 10.2147/TCRM.S201162. eCollection 2019.

Currently, atrial fibrillation (AF) is the most common sustained cardiac arrhythmia, with a prevalence of about 2-3% in the general population, representing a powerful risk factor for stroke and systemic thromboembolism and increased mortality and morbidity. Restoration of sinus...

Cite
Lavalle C, Straito M, Caroli A, et al. Rivaroxaban in atrial fibrillation cardioversion: an update. Ther Clin Risk Manag. 2019;15:613-626doi: 10.2147/TCRM.S201162.
Lavalle, C., Straito, M., Caroli, A., Piro, A., Giunta, G., Mariani, M. V., & Fedele, F. (2019). Rivaroxaban in atrial fibrillation cardioversion: an update. Therapeutics and clinical risk management, 15613-626. https://doi.org/10.2147/TCRM.S201162
Lavalle, Carlo, et al. "Rivaroxaban in atrial fibrillation cardioversion: an update." Therapeutics and clinical risk management vol. 15 (2019): 613-626. doi: https://doi.org/10.2147/TCRM.S201162
Lavalle C, Straito M, Caroli A, Piro A, Giunta G, Mariani MV, Fedele F. Rivaroxaban in atrial fibrillation cardioversion: an update. Ther Clin Risk Manag. 2019 May 02;15:613-626. doi: 10.2147/TCRM.S201162. eCollection 2019. PMID: 31118649; PMCID: PMC6504667.
Copy Download .nbib Format: NLM
Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib.

Oncotarget

Montenegro RC, Howarth A, Ceroni A, Fedele V, Farran B, Mesquita FP, Frejno M, Berger BT, Heinzlmeir S, Sailem HZ, Tesch R, Ebner D, Knapp S, Burbano R, Kuster B, Müller S.
PMID: 32082487
Oncotarget. 2020 Feb 04;11(5):535-549. doi: 10.18632/oncotarget.27462. eCollection 2020 Feb 04.

Gastric cancer (GC) remains the third leading cause of cancer-related death despite several improvements in targeted therapy. There is therefore an urgent need to investigate new treatment strategies, including the identification of novel biomarkers for patient stratification. In this...

Cite
Montenegro RC, Howarth A, Ceroni A, et al. Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget. 2020;11(5):535-549doi: 10.18632/oncotarget.27462.
Montenegro, R. C., Howarth, A., Ceroni, A., Fedele, V., Farran, B., Mesquita, F. P., Frejno, M., Berger, B. T., Heinzlmeir, S., Sailem, H. Z., Tesch, R., Ebner, D., Knapp, S., Burbano, R., Kuster, B., & Müller, S. (2020). Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget, 11(5), 535-549. https://doi.org/10.18632/oncotarget.27462
Montenegro, Raquel Carvalho, et al. "Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib." Oncotarget vol. 11,5 (2020): 535-549. doi: https://doi.org/10.18632/oncotarget.27462
Montenegro RC, Howarth A, Ceroni A, Fedele V, Farran B, Mesquita FP, Frejno M, Berger BT, Heinzlmeir S, Sailem HZ, Tesch R, Ebner D, Knapp S, Burbano R, Kuster B, Müller S. Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget. 2020 Feb 04;11(5):535-549. doi: 10.18632/oncotarget.27462. eCollection 2020 Feb 04. PMID: 32082487; PMCID: PMC7007292.
Copy Download .nbib Format: NLM
On flavourful Easter eggs for New Physics hunger and lepton flavour universality violation.

The European physical journal. C, Particles and fields

Ciuchini M, Coutinho AM, Fedele M, Franco E, Paul A, Silvestrini L, Valli M.
PMID: 31997924
Eur Phys J C Part Fields. 2017;77(10):688. doi: 10.1140/epjc/s10052-017-5270-2. Epub 2017 Oct 17.

Within the standard approach of effective field theory of weak interactions for

Cite
Ciuchini M, Coutinho AM, Fedele M, et al. On flavourful Easter eggs for New Physics hunger and lepton flavour universality violation. Eur Phys J C Part Fields. 2017;77(10):688doi: 10.1140/epjc/s10052-017-5270-2.
Ciuchini, M., Coutinho, A. M., Fedele, M., Franco, E., Paul, A., Silvestrini, L., & Valli, M. (2017). On flavourful Easter eggs for New Physics hunger and lepton flavour universality violation. The European physical journal. C, Particles and fields, 77(10), 688. https://doi.org/10.1140/epjc/s10052-017-5270-2
Ciuchini, Marco, et al. "On flavourful Easter eggs for New Physics hunger and lepton flavour universality violation." The European physical journal. C, Particles and fields vol. 77,10 (2017): 688. doi: https://doi.org/10.1140/epjc/s10052-017-5270-2
Ciuchini M, Coutinho AM, Fedele M, Franco E, Paul A, Silvestrini L, Valli M. On flavourful Easter eggs for New Physics hunger and lepton flavour universality violation. Eur Phys J C Part Fields. 2017;77(10):688. doi: 10.1140/epjc/s10052-017-5270-2. Epub 2017 Oct 17. PMID: 31997924; PMCID: PMC6956931.
Copy Download .nbib Format: NLM
Spherical aberrations in the thermal-wave model for luminosity estimates in particle accelerators.

Physical review. A, Atomic, molecular, and optical physics

Fedele R, Miele G.
PMID: 9907973
Phys Rev A. 1992 Nov 15;46(10):6634-6639. doi: 10.1103/physreva.46.6634.

No abstract available.

Cite
Fedele R, Miele G. Spherical aberrations in the thermal-wave model for luminosity estimates in particle accelerators. Phys Rev A. 1992;46(10):6634-6639doi: 10.1103/physreva.46.6634.
Fedele, R., & Miele, G. (1992). Spherical aberrations in the thermal-wave model for luminosity estimates in particle accelerators. Physical review. A, Atomic, molecular, and optical physics, 46(10), 6634-6639. https://doi.org/10.1103/physreva.46.6634
Fedele, and Miele. "Spherical aberrations in the thermal-wave model for luminosity estimates in particle accelerators." Physical review. A, Atomic, molecular, and optical physics vol. 46,10 (1992): 6634-6639. doi: https://doi.org/10.1103/physreva.46.6634
Fedele R, Miele G. Spherical aberrations in the thermal-wave model for luminosity estimates in particle accelerators. Phys Rev A. 1992 Nov 15;46(10):6634-6639. doi: 10.1103/physreva.46.6634. PMID: 9907973.
Copy Download .nbib Format: NLM
Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors.

European journal of preventive cardiology

Severino P, D'Amato A, Netti L, Pucci M, Mariani MV, Cimino S, Birtolo LI, Infusino F, De Orchi P, Palmirotta R, Lovero D, Silvestris F, Caputo V, Pizzuti A, Miraldi F, Maestrini V, Mancone M, Fedele F.
PMID: 33611546
Eur J Prev Cardiol. 2020 Jun 02; doi: 10.1177/2047487320926780. Epub 2020 Jun 02.

AIMS: Ischaemic heart disease is classically associated with coronary artery disease. Recent evidences showed the correlation between coronary microvascular dysfunction and ischaemic heart disease, even independently of coronary artery disease. Ion channels represent the final effectors of blood flow...

Cite
Severino P, D'Amato A, Netti L, et al. Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors. Eur J Prev Cardiol. 2020;doi: 10.1177/2047487320926780.
Severino, P., D'Amato, A., Netti, L., Pucci, M., Mariani, M. V., Cimino, S., Birtolo, L. I., Infusino, F., De Orchi, P., Palmirotta, R., Lovero, D., Silvestris, F., Caputo, V., Pizzuti, A., Miraldi, F., Maestrini, V., Mancone, M., & Fedele, F. (2020). Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors. European journal of preventive cardiology, . https://doi.org/10.1177/2047487320926780
Severino, Paolo, et al. "Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors." European journal of preventive cardiology vol. (2020). doi: https://doi.org/10.1177/2047487320926780
Severino P, D'Amato A, Netti L, Pucci M, Mariani MV, Cimino S, Birtolo LI, Infusino F, De Orchi P, Palmirotta R, Lovero D, Silvestris F, Caputo V, Pizzuti A, Miraldi F, Maestrini V, Mancone M, Fedele F. Susceptibility to ischaemic heart disease: Focusing on genetic variants for ATP-sensitive potassium channel beyond traditional risk factors. Eur J Prev Cardiol. 2020 Jun 02; doi: 10.1177/2047487320926780. Epub 2020 Jun 02. PMID: 33611546.
Copy Download .nbib Format: NLM
Daily adherence variability and psychosocial differences in adolescents with asthma: a pilot study.

Journal of behavioral medicine

Sweenie R, Cushing CC, Fleming KK, Prabhakaran S, Fedele DA.
PMID: 34357514
J Behav Med. 2021 Aug 06; doi: 10.1007/s10865-021-00247-5. Epub 2021 Aug 06.

Adolescents with asthma endorse psychosocial difficulties as barriers to inhaled corticosteroid adherence. This study examined patterns of variability in adherence and within-person associations of psychosocial variables with adherence across days. Participants included twenty-five adolescents (M

Cite
Sweenie R, Cushing CC, Fleming KK, et al. Daily adherence variability and psychosocial differences in adolescents with asthma: a pilot study. J Behav Med. 2021;doi: 10.1007/s10865-021-00247-5.
Sweenie, R., Cushing, C. C., Fleming, K. K., Prabhakaran, S., & Fedele, D. A. (2021). Daily adherence variability and psychosocial differences in adolescents with asthma: a pilot study. Journal of behavioral medicine, . https://doi.org/10.1007/s10865-021-00247-5
Sweenie, Rachel, et al. "Daily adherence variability and psychosocial differences in adolescents with asthma: a pilot study." Journal of behavioral medicine vol. (2021). doi: https://doi.org/10.1007/s10865-021-00247-5
Sweenie R, Cushing CC, Fleming KK, Prabhakaran S, Fedele DA. Daily adherence variability and psychosocial differences in adolescents with asthma: a pilot study. J Behav Med. 2021 Aug 06; doi: 10.1007/s10865-021-00247-5. Epub 2021 Aug 06. PMID: 34357514.
Copy Download .nbib Format: NLM
Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC.

Cancer discovery

Tang KH, Li S, Khodadadi-Jamayran A, Jen J, Han H, Guidry K, Chen T, Hao Y, Fedele C, Zebala JA, Maeda DY, Christensen JG, Olson P, Athanas A, Loomis CA, Tsirigos A, Wong KK, Neel BG.
PMID: 34353854
Cancer Discov. 2021 Aug 05; doi: 10.1158/2159-8290.CD-21-0369. Epub 2021 Aug 05.

SHP2 inhibitors (SHP2i) alone and in various combinations are being tested in multiple tumors with over-activation of the RAS/ERK pathway. SHP2 plays critical roles in normal cell signaling; hence, SHP2is could influence the tumor microenvironment. We found that SHP2i...

Cite
Tang KH, Li S, Khodadadi-Jamayran A, et al. Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC. Cancer Discov. 2021;doi: 10.1158/2159-8290.CD-21-0369.
Tang, K. H., Li, S., Khodadadi-Jamayran, A., Jen, J., Han, H., Guidry, K., Chen, T., Hao, Y., Fedele, C., Zebala, J. A., Maeda, D. Y., Christensen, J. G., Olson, P., Athanas, A., Loomis, C. A., Tsirigos, A., Wong, K. K., & Neel, B. G. (2021). Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC. Cancer discovery, . https://doi.org/10.1158/2159-8290.CD-21-0369
Tang, Kwan Ho, et al. "Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC." Cancer discovery vol. (2021). doi: https://doi.org/10.1158/2159-8290.CD-21-0369
Tang KH, Li S, Khodadadi-Jamayran A, Jen J, Han H, Guidry K, Chen T, Hao Y, Fedele C, Zebala JA, Maeda DY, Christensen JG, Olson P, Athanas A, Loomis CA, Tsirigos A, Wong KK, Neel BG. Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC. Cancer Discov. 2021 Aug 05; doi: 10.1158/2159-8290.CD-21-0369. Epub 2021 Aug 05. PMID: 34353854.
Copy Download .nbib Format: NLM
The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients.

Gynecologic oncology

Ronsini C, Anchora LP, Restaino S, Fedele C, Arciuolo D, Teodorico E, Bizzarri N, Zannoni GF, Ferrandina G, Scambia G, Fanfani F.
PMID: 34116834
Gynecol Oncol. 2021 Aug;162(2):299-307. doi: 10.1016/j.ygyno.2021.06.002. Epub 2021 Jun 09.

OBJECTIVE: Lymph vascular space involvement (LVSI) is one of the most important prognostic factors in early stage cervical cancer. Its qualitative evaluation represents a milestone for patient risk stratification and treatment choice, but a semi-quantitative analysis of LVSI may...

Cite
Ronsini C, Anchora LP, Restaino S, et al. The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients. Gynecol Oncol. 2021;162(2):299-307doi: 10.1016/j.ygyno.2021.06.002.
Ronsini, C., Anchora, L. P., Restaino, S., Fedele, C., Arciuolo, D., Teodorico, E., Bizzarri, N., Zannoni, G. F., Ferrandina, G., Scambia, G., & Fanfani, F. (2021). The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients. Gynecologic oncology, 162(2), 299-307. https://doi.org/10.1016/j.ygyno.2021.06.002
Ronsini, Carlo, et al. "The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients." Gynecologic oncology vol. 162,2 (2021): 299-307. doi: https://doi.org/10.1016/j.ygyno.2021.06.002
Ronsini C, Anchora LP, Restaino S, Fedele C, Arciuolo D, Teodorico E, Bizzarri N, Zannoni GF, Ferrandina G, Scambia G, Fanfani F. The role of semiquantitative evaluation of lympho-vascular space invasion in early stage cervical cancer patients. Gynecol Oncol. 2021 Aug;162(2):299-307. doi: 10.1016/j.ygyno.2021.06.002. Epub 2021 Jun 09. PMID: 34116834.
Copy Download .nbib Format: NLM
Modified Technique for Wirsung-Pancreatogastric Anastomosis after Pancreatoduodenectomy: A Single Center Experience and Systematic Review of the Literature.

Journal of clinical medicine

Bizzoca C, Fedele S, Lippolis AS, Aquilino F, Castellana M, Basile MR, Lucarelli G, Vincenti L.
PMID: 34300229
J Clin Med. 2021 Jul 11;10(14). doi: 10.3390/jcm10143064.

BACKGROUND: The mortality rate following pancreaticoduodenectomy (PD) has been decreasing over the past few years; nonetheless, the morbidity rate remains elevated. The most common complications after PD are post-operative pancreatic fistula (POPF) and delayed gastric emptying (DGE) syndrome. The...

Cite
Bizzoca C, Fedele S, Lippolis AS, et al. Modified Technique for Wirsung-Pancreatogastric Anastomosis after Pancreatoduodenectomy: A Single Center Experience and Systematic Review of the Literature. J Clin Med. 2021;10(14)doi: 10.3390/jcm10143064.
Bizzoca, C., Fedele, S., Lippolis, A. S., Aquilino, F., Castellana, M., Basile, M. R., Lucarelli, G., & Vincenti, L. (2021). Modified Technique for Wirsung-Pancreatogastric Anastomosis after Pancreatoduodenectomy: A Single Center Experience and Systematic Review of the Literature. Journal of clinical medicine, 10(14), . https://doi.org/10.3390/jcm10143064
Bizzoca, Cinzia, et al. "Modified Technique for Wirsung-Pancreatogastric Anastomosis after Pancreatoduodenectomy: A Single Center Experience and Systematic Review of the Literature." Journal of clinical medicine vol. 10,14 (2021). doi: https://doi.org/10.3390/jcm10143064
Bizzoca C, Fedele S, Lippolis AS, Aquilino F, Castellana M, Basile MR, Lucarelli G, Vincenti L. Modified Technique for Wirsung-Pancreatogastric Anastomosis after Pancreatoduodenectomy: A Single Center Experience and Systematic Review of the Literature. J Clin Med. 2021 Jul 11;10(14). doi: 10.3390/jcm10143064. PMID: 34300229; PMCID: PMC8303560.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 312 entries